Quantitative testing of liver function in relation to fibrosis in patients with chronic hepatitis B and C

Liver

Volumn 21, Issue 4, 2001, Pages 260-265

  Herold, Christoph ^a   Heinz, Rudolf ^a   Niedobitek, Gerald ^a   Schneider, Thomas ^a   Hahn, Eckhart G ^a   Schuppan, Detlef ^a,b  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

Chronic hepatitis B and C; Liver fibrosis; Quantitative testing of liver function

Indexed keywords

AMINOPHENAZONE; GALACTOSE; INDOCYANINE GREEN; SORBITOL;

ADULT; ARTICLE; BREATH ANALYSIS; CLEARANCE; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; GENOTYPE; HEPATITIS B; HEPATITIS C; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FIBROSIS; LIVER FUNCTION; LIVER METABOLISM; LIVER PERFUSION; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; STAGING; VIRUS INFECTION;

ADULT; FEMALE; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HUMANS; LIVER; LIVER CIRRHOSIS; LIVER FUNCTION TESTS; MALE; MIDDLE AGED;

EID: 0034919632     PISSN: 01069543     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0676.2001.021004260.x     Document Type: Article

References (35)

1. Quantitative liver function in patients with cirrhosis due to chronic hepatitis C to assess disease severity
2. Parameters of liver function but not of liver perfusion predict portal vein velocity in noncirrhotic patients with chronic hepatitis C
3. 14C-aminopyrine
4. A simple method for routine determination of the metabolic liver capacity: The aminopyrine breath test
5. Prognostic evaluation in alcoholic cirrhosis
6. Microsomal liver function declines steadily after kidney grafting: A three to five year follow-up
7. Estimation of hepatic blood flow with indocyanine green
8. Interpretation of simultaneous measurements of hepatic extraction fractions of indocyanine green and sorbitol: Evidence of hepatic shunts and capillarization?
9. Steady-state extrarenal sorbitol clearance as a measure of hepatic plasma flow
10. D-sorbitol clearance
11. The nomenclature of chronic active hepatitis
12. Histopathologic diagnosis and terminology of chronic hepatitis
13. Surgery and portal hypertension
14. Classification of hepatitis C virus into six major genotypes and a series of subtypes
15. 14C-aminopyrine breath test values in patients with chronic hepatitis C
16. Fixed versus titrated interferon alpha 2b in chronic hepatitis. A randomized controlled multicenter trial
17. Hepatic blood flow changes in chronic hepatitis C measured by duplex Doppler color sonography: Relationship to histological features
18. 14C-aminopyrine breath test analysis and conventional biochemical tests as predictors of survival in cirrhosis
19. Prognostic value of galactose elimination capacity, aminopyrine breath test and ICG clearance: Comparison with the Pugh score
20. 14C aminopyrine breath test
21. Prognostic significance of hepatic venous pressure gradient in medically treated alcoholic cirrhosis: Comparison to aminopyrine breath test
22. The aminopyrine breath test does not correlate with histologic disease severity in patients with cholestasis
23. Accurate prediction of death by serial determination of galactose elimination capacity (GEC) in primary biliary cirrhosis. A comparison with the Mayo-Score
24. Galactose elimination capacity as a prognostic index in patients with fulminant liver failure
25. Sorbitol as a test substance for measurement of liver plasma flow in humans
26. Non-invasive evaluation of portal-systemic shunting in man by D-Sorbitol bioavailability
27. Indocyanine green clearance as a predictor of successful hepatic resection in cirrhotic patients
28. Indocyanine green intrinsic hepatic clearance as a prognostic index of survival in patients with cirrhosis
29. Is hepatic resection absolutely contraindicated for hepatocellular carcinoma in Child-Pugh class C cirrhotic patients?
30. Liver function tests in a clinical comparison
31. Indocyanine green clearance reflects reperfusion injury following liver transplantation and is an early predictor of graft function
32. Effect of chronic treatment with nadolol plus isosorbide mononitrate on liver blood flow and metabolic activity in cirrhosis
33. Liver volume, portal vein flow and clearance of indocyanine green and antipyrine in hyperthyroidism before and after antithyroid treatment
34. Herbal products for liver diseases: A therapeutic challenge for the new Millennium